Zelnorm (tegaserod), a new drug for irritable bowel syndrome

Novartis will soon market Zelnorm (tegaserod), a new drug for irritable bowel syndrome.

It will be available first in Canada...later in the U.S.

Zelnorm will be used to treat CONSTIPATION-predominant IBS. It is approved for use only in women due to a lack of data for men.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote